ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Effects of the Novel PKCθ Selective Inhibitor AS2521780 on Acute Rejection in Rats and Monkeys

    N. Chida, T. Kawashima, M. Tasaki, H. Matsuoka, M. Maeda, A. Tanaka, Y. Higashi

    Molecular Medicine Research Labs, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan; Pharmacological Research Labs, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan; Chemical Research Labs, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan

    BackgroundInhibition of T-cell activation is the most effective to prevent acute cellular rejection. Protein kinase C (PKC) theta is a crucial signaling enzyme in the…
  • 2013 American Transplant Congress

    Donor Hepatitis C Status Does Not Impact Outcomes in Hepatitis C Positive Kidney Transplant Recipients

    P. Jawa, J. Knorr, E. Torres, R. Raja, G. Bradauskaite, S. Kung

    Transplant Nephrology, Einstein Medical Center, Philadelphia, PA; Pharmacy, Einstein Medical Center, Philadelphia, PA; , Select

    Background:The kidneys from HCV positive donors remain to be underutilized, as there are multiple studies which have shown reduced patient and graft survival rates among…
  • 2013 American Transplant Congress

    Deletion of CD98hc in Lymphocytes Results in Increasing Treg Cell To Prevent Acute Murine GvHD

    X. Li, Y. Kitajima, Y. Nishio, T. Saito, H. Tsumura, Y. Nagahara, S. Cai

    National Research Institute for Child Health and Development, Tokyo, Japan; Tokyo Denki University, Saitama, Japan

    CD98 heavy chain (CD98hc), encoded by Slc3a2, is a widely expressed vertebrate membrane protein whose functions are known as facilitating amino acid transporter and mediating…
  • 2013 American Transplant Congress

    Modulation of Allogeneic CD8+ T Cell Response by Histone Methylation Inhibitor DZNep Can Control GVHD While Preserving Hematopoietic Chimerism

    J. Wang, M. Xu, R. Rong, Y. Zhang, T. Zhu

    Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Organ Transplantation, Shanghai, China; Department of Internal Medicine, University of Michigan, Ann Arbor, MI

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) following solid-organ transplantation is a feasible method to achieve long-lasting organ allograft tolerance through the induction of hematopoietic chimerism…
  • 2013 American Transplant Congress

    Assessment of Vitamin D and Changes in Bone Mineral Density in a Predominantly African American Pediatric Kidney Transplant Population

    A. Moudgil, L. Ryan, S. Tuchman, K. Sgambat

    Children's National, Washington, DC

    Purpose The purpose of this study was to investigate nutritional Vitamin D (Vit D) deficiency and changes in bone mineral density (BMD) over 1 year…
  • 2013 American Transplant Congress

    Risk of Recurrence of Pre-Existing Cancer in Organ Recipients

    R. Desai, D. Collett, C. Watson, P. Johnson, T. Evans, J. Neuberger

    Organ Donation and Transplantation, National Health Service Blood and Transplant, Bristol, United Kingdom; Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; West Midlands Cancer Intelligence Unit, University of Birmingham, Birmingham, United Kingdom

    A past history of cancer is a relative contraindication to undergoing organ transplantation because of the risk of recurrence of cancer. However, the extent of…
  • 2013 American Transplant Congress

    Health-Related Quality of Life (HRQOL) of Recipients after Living-Donor Liver Transplantation (LDLT)

    J. Togashi, Y. Sugawara, N. Akamatsu, S. Tamura, J. Kaneko, T. Aoki, Y. Sakamoto, K. Hasegawa, N. Kokudo

    Artificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan

    With the improvement of patient survival after living-donor liver transplantation (LDLT), not only a simple survey of mortality and morbidity but also health-related quality of…
  • 2013 American Transplant Congress

    HLA-Antigens as a Risk Factor in Polyomavirus BK Viremia

    P. Randhawa, T. Ninomiya, K. Masutani

    Pathology, University of Pittsburgh, Pittsburgh; Medicine and Clinical Science, Kyushu University, Fukuoka, Japan

    Identification of HLA-antigens that modulate immunity to polyomavirus BK (BKV) infection could be used to (a) fine tune virus screening strategies in individual patients, and…
  • 2013 American Transplant Congress

    Alloimmune and Non-Alloimmune Kidney Graft Losses, Improving Our Understanding of Factors Associated with Failure

    F. Cosio, E. Rodrigo, M. El Ters, B. Chopra, E. Lorenz, M. Stegall

    Nephrology,Transplant Center, Mayo Clinic, Rochester, MN; Surgery, Transplant Center, Mayo Clinic, Rochester, MN

    Introduction. Death-censored graft loss (GL) is generally analyzed as a single endpoint. However, GL has multiple causes, alloimmune (GLA, acute rejection, chronic antibody rejection) and…
  • 2013 American Transplant Congress

    Critical Role of Allograft Infiltrating ROR Gamma t Positive Innate Immune Cells and Hematopoietic Progenitor Cells

    Z. Fan, K. Jung, S. Yun, T. Strom, M. Koulmanda

    The Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Using a minimally invasive in vivo imaging system to serially monitor fluorescence emitting T cell subtypes infiltrating islet allografts, we have now probed for the…
  • « Previous Page
  • 1
  • …
  • 1550
  • 1551
  • 1552
  • 1553
  • 1554
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences